Status:
COMPLETED
Autonomic Modulation After Spinal Anesthesia With Depth of Anesthesia and Vital Signs.
Lead Sponsor:
National Central University
Conditions:
Participants Scheduled for Surgery Under Spinal Anesthesia Without Impairment of Renal, Hepatic, Cardiac or Respiratory Function
Eligibility:
All Genders
20-80 years
Brief Summary
Spinal anaesthesia has the advantage that produced nerve block by the injection of local anaesthetic into cerebrospinal fluid (CSF). However, the greatest challenge in spinal anaesthesia is to control...
Detailed Description
The activity of the autonomic nervous system is of fundamental importance in the regulation of vital bodily functions. Unbalance of autonomic nerve system results in considerably disordered vital func...
Eligibility Criteria
Inclusion
- 1\. patients scheduled for operation with spinal anesthesia
Exclusion
- recently treat with a sedative, beta-blocker, parasympatholytic, or opioid agent
- emergency surgery
- hypovolemia and hypothermia, arrhythmia, diabetes, or impairment of renal, hepatic, coagulation, cardiac, or respiratory function
Key Trial Info
Start Date :
March 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 16 2019
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04275375
Start Date
March 1 2019
End Date
August 16 2019
Last Update
July 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Veterans General Hospital
Taipei, R.o.c, Taiwan, 11217